Any current/future new fundraising through debt or equity?

No explicit mention of current or future fundraising through debt or equity in the transcript. Refinery long-term loan stands at Rs. 200 crores, unchanged from last year. Short-term loans have decreased compared to last year (Rs. 220 crores vs Rs. 596 crores previously). Discussions on distillery expansion and product development do not indicate any large CAPEX or fundraising currently. Nutraceutical segment under strategic review, with no major CAPEX planned. Management focuses on operational improvement and strategic partnerships rather than immediate financing. Any future CAPEX or funding d

Any current/future capex/capital investment/strategic investment?

No major CAPEX planned currently for the Nutraceutical segment; ongoing strategic review to define future investments. Critical investments around science and product development in Nutraceuticals will continue as needed. Evaluation ongoing for potential conversion of sugarcane-based distillery to multi-grain based, but no finalized CAPEX yet. Refinery business seeking to improve operational metrics possibly via partnerships; no specific CAPEX details shared. Retail branded staples and non-sweetener businesses being built with an asset-light model, implying low capital intensity. Future plans

Future growth expectations in sales/revenue/volumes?

Refinery volumes to increase institutional sales from current 10-15% to over one-third in 1-2 years (Page 16). Consumer Product Group (CPG) retail staples business growing; revenue rose from Rs. 10 crores in April to Rs. 25.2 crores in June, with expanding distribution to ~1.5 lakh outlets in South India (Pages 7-9). Staples revenue expected to grow progressively, adding new SKUs and portfolio expansion based on consumer relevance (Pages 9-10). Sugarcane crushing and sugar volumes expected to at least match last year's numbers (Page 11). Distillery capacity (582 KLPD) fully operational

Future growth expectations in earnings/operating earnings/profits/EPS?

Refinery business is showing improvement with reduced losses (Q1 loss Rs. 6.79 crores vs. Rs. 96.51 crores last year), indicating improving profitability. Institutional sales in refinery currently 10-15%, target to increase to over one-third, which could improve margins with $10-$25/ton premiums over white sugar. Consumer Products Group (CPG) growing strongly with 67% revenue growth; non-sweetener staples category at early stage but expanding (Rs. 25 crores in June). Distillery operations expanded to 582 KLPD capacity by June, supporting higher alcohol sales and revenues. Sugarcane availabilit

IN US

Sale is live|00:00:00left today

EID Parry (India) LtdQ2 FY24Food Products

EID Parry (India) Ltd Q2 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹708P/E: 13.3Market Cap: ₹14.0K CrSector: Food Products

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 2 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Refinery volumes to increase institutional sales from current 10-15% to over one-third in 1-2 years (Page 16).
→Consumer Product Group (CPG) retail staples business growing; revenue rose from Rs. 10 crores in April to Rs. 25.2 crores in June, with expanding distribution to ~1.5 lakh outlets in South India (Pages 7-9).
→Staples revenue expected to grow progressively, adding new SKUs and portfolio expansion based on consumer relevance (Pages 9-10).
→Sugarcane crushing and sugar volumes expected to at least match last year's numbers (Page 11).
→Distillery capacity (582 KLPD) fully operational as of June, supporting higher alcohol sales (Page 15).
→Nutra segment under strategic review with no major CAPEX; sticking mainly to current products but exploring some clinical work (Page 10).
→Expansion in retail staples is currently asset-light and independent of sugarcane operations (Page 9).

Margin guidance

Category 3

→Refinery business is showing improvement with reduced losses (Q1 loss Rs. 6.79 crores vs. Rs. 96.51 crores last year), indicating improving profitability.
→Institutional sales in refinery currently 10-15%, target to increase to over one-third, which could improve margins with $10-$25/ton premiums over white sugar.
→Consumer Products Group (CPG) growing strongly with 67% revenue growth; non-sweetener staples category at early stage but expanding (Rs. 25 crores in June).
→Distillery operations expanded to 582 KLPD capacity by June, supporting higher alcohol sales and revenues.
→Sugarcane availability challenges remain; aiming to match previous year’s crushing volume despite monsoon impacts.
→Nutraceutical segment under strategic review; no major CAPEX or new launches expected short-term, focusing on efficient business operations.
→Focus on building distribution and higher gross margin products in food FMCG over time to improve overall profitability.

3 more insights locked — sign up free to unlock

Fundraise plans

→No explicit mention of current or future fundraising through debt or equity in the transcript.
→Refinery long-term loan stands at Rs. 200 crores, unchanged from last year.
→Short-term loans have decreased compared to last year (Rs. 220 crores vs Rs. 596 crores previously).
→Discussions on distillery expansion and product development do not indicate any large CAPEX or fundraising currently.
→Nutraceutical segment under strategic review, with no major CAPEX planned.
→Management focuses on operational improvement and strategic partnerships rather than immediate financing.
→Any future CAPEX or funding decisions likely to be communicated once business strategies are clearer.

Order book

The transcript does not explicitly mention current or expected order book or pending orders for E.I.D.- Parry (India) Limited. However, some relevant operational insights include: - Refinery sales significantly increased to 2.23 LMT versus 1.33 LMT last year, indicating strong demand. - Non-sweetener retail business is in early stages with Rs. 25 crore revenue in the quarter and about 1.5 lakh distribution outlets in southern India. - Expansion plans include increasing institutional sales in refinery from current 10-15% to over one third. - Launch of new products like "Amrit" brown sugar for market penetration. - Distillery operations ramped up to 582 KLPD capacity. - No specific numerical data on order book or pending orders disclosed. Overall, the company is focusing on ramping up production capacities, distribution reach, and institutional customer base without a formal order book disclosure.

Capex plans

→No major CAPEX planned currently for the Nutraceutical segment; ongoing strategic review to define future investments.
→Critical investments around science and product development in Nutraceuticals will continue as needed.
→Evaluation ongoing for potential conversion of sugarcane-based distillery to multi-grain based, but no finalized CAPEX yet.
→Refinery business seeking to improve operational metrics possibly via partnerships; no specific CAPEX details shared.
→Retail branded staples and non-sweetener businesses being built with an asset-light model, implying low capital intensity.
→Future plans include expanding sourcing efficiency and exploring Coromandel connect for sourcing, no explicit CAPEX mentioned.
→Overall, focused on building distribution and product portfolio first before significant gross margin improvements and related investments.

How does EID Parry (India) Ltd rank vs peers in Food Products?

Pro feature

1EID Parry (India) Ltd

Rev 3Mar 3

See full Food Products sector rankings

Want more stocks like EID Parry (India) Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio